BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9416724)

  • 1. The effect of halothane on the recirculatory pharmacokinetics of physiologic markers.
    Avram MJ; Krejcie TC; Niemann CU; Klein C; Gentry WB; Shanks CA; Henthorn TK
    Anesthesiology; 1997 Dec; 87(6):1381-93. PubMed ID: 9416724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoflurane alters the recirculatory pharmacokinetics of physiologic markers.
    Avram MJ; Krejcie TC; Niemann CU; Enders-Klein C; Shanks CA; Henthorn TK
    Anesthesiology; 2000 Jun; 92(6):1757-68. PubMed ID: 10839928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications of blood volume alter the disposition of markers of blood volume, extracellular fluid, and total body water.
    Krejcie TC; Henthorn TK; Gentry WB; Niemann CU; Enders-Klein C; Shanks CA; Avram MJ
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1308-16. PubMed ID: 10565856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly.
    Krejcie TC; Henthorn TK; Niemann CU; Klein C; Gupta DK; Gentry WB; Shanks CA; Avram MJ
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1050-7. PubMed ID: 8819485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
    Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
    J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recirculatory pharmacokinetic model describing the circulatory mixing, tissue distribution and elimination of antipyrine in dogs.
    Krejcie TC; Henthorn TK; Shanks CA; Avram MJ
    J Pharmacol Exp Ther; 1994 May; 269(2):609-16. PubMed ID: 8182527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced hemodynamic perturbations alter the disposition of markers of blood volume, extracellular fluid, and total body water.
    Krejcie TC; Wang Z; Avram MJ
    J Pharmacol Exp Ther; 2001 Mar; 296(3):922-30. PubMed ID: 11181925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine distribution described by a recirculatory pharmacokinetic model is not stereoselective.
    Henthorn TK; Krejcie TC; Niemann CU; Enders-Klein C; Shanks CA; Avram MJ
    Anesthesiology; 1999 Dec; 91(6):1733-43. PubMed ID: 10598617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concordance of early antipyrine and thiopental distribution kinetics.
    Avram MJ; Krejcie TC; Henthorn TK
    J Pharmacol Exp Ther; 2002 Aug; 302(2):594-600. PubMed ID: 12130720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative disposition of pharmacologic markers for cytochrome P-450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogs.
    KuKanich B; Coetzee JF; Gehring R; Hubin M
    J Vet Pharmacol Ther; 2007 Aug; 30(4):314-9. PubMed ID: 17610404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indocyanine green kinetics characterize blood volume and flow distribution and their alteration by propranolol.
    Niemann CU; Henthorn TK; Krejcie TC; Shanks CA; Enders-Klein C; Avram MJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):342-50. PubMed ID: 10801242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulatory transport and capillary-tissue exchange as determinants of the distribution kinetics of inulin and antipyrine in dog.
    Weiss M; Krejcie TC; Avram MJ
    J Pharm Sci; 2007 Apr; 96(4):913-26. PubMed ID: 17221855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects.
    Andersen V; Sonne J; Larsen S
    Scand J Gastroenterol; 1999 Aug; 34(8):813-7. PubMed ID: 10499483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recirculatory pharmacokinetics and pharmacodynamics of rocuronium in patients: the influence of cardiac output.
    Kuipers JA; Boer F; Olofsen E; Bovill JG; Burm AG
    Anesthesiology; 2001 Jan; 94(1):47-55. PubMed ID: 11135721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transit time dispersion in pulmonary and systemic circulation: effects of cardiac output and solute diffusivity.
    Weiss M; Krejcie TC; Avram MJ
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H861-70. PubMed ID: 16501020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal compartmental model of circulatory mixing of indocyanine green.
    Henthorn TK; Avram MJ; Krejcie TC; Shanks CA; Asada A; Kaczynski DA
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H903-10. PubMed ID: 1558199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic drug clearance in patients with mild cystic fibrosis.
    Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE
    Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recirculatory and compartmental pharmacokinetic modeling of alfentanil in pigs: the influence of cardiac output.
    Kuipers JA; Boer F; Olofsen E; Olieman W; Vletter AA; Burm AG; Bovill JG
    Anesthesiology; 1999 Apr; 90(4):1146-57. PubMed ID: 10201688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of buprenorphine in anesthetized dogs.
    Martinez EA; Hartsfield SM; Melendez LD; Matthews NS; Slater MR
    Am J Vet Res; 1997 Nov; 58(11):1280-4. PubMed ID: 9361893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac and regional hemodynamic interactions between halothane and nitric oxide synthase activity in dogs.
    Chelly JE; Doursout MF; Lechevalier T; Liang YY; Chelly F; Hartley C; Kilbourn RG
    Anesthesiology; 1996 Jul; 85(1):142-9. PubMed ID: 8694360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.